18+ · Research Use Only · Not for Human Consumption

Research / Protocol library

Compounds, studied together.

Curated research stacks, peptides that appear together in published literature, organised by the research areas they span. Strictly investigational reference.

5 research protocols

01 · Research protocol

Soft-Tissue & Connective Repair

The two compounds most frequently studied together in tendon, ligament, and connective-tissue research.

Composition

2 compounds

1 in stock · 1 restock pending

Tendon & ligament repairAngiogenesisGastrointestinal mucosaActin regulation

Pentadecapeptide BPC-157 and Thymosin Beta-4 fragment TB-500 are the canonical pairing in soft-tissue repair literature. Research investigates both compounds for their roles in angiogenesis, cell migration, and tissue remodeling, BPC-157 derived from a protective gastric protein, TB-500 as an actin-sequestering fragment. The two are commonly co-studied in tendon, ligament, gastrointestinal mucosa, and broader connective-tissue contexts.

Literature window

Published studies in this area typically report endpoints across multi-week observation windows rather than acute timeframes.

Compounds in this protocol

  • BPC-157 20mg vial
    PRM-002 · Recovery

    BPC-157 / 20mg

    Pentadecapeptide derived from a protective gastric protein, studied for tissue repair and angiogenic activity.

    ₱2,020₱2,240
    View vial
  • TB-500 5mg vial
    PRM-008 · Recovery

    TB-500 / 5mg

    Synthetic fragment of Thymosin Beta-4 investigated for actin sequestration, cell migration and connective-tissue repair.

02 · Research protocol

GLP-1 / Metabolic Regulation

Incretin-mimetic research compounds studied for metabolic and energy expenditure pathways.

Composition

2 compounds

1 in stock · 1 restock pending

GLP-1 / GIP / Glucagon agonismGlycemic controlEnergy expenditureLipid metabolism

Investigational incretin-mimetics, Retatrutide as a triple GLP-1 / GIP / glucagon agonist, Tirzepatide as a dual GLP-1 / GIP agonist, are studied in metabolic regulation research. The literature explores receptor agonism mechanisms, glycemic control endpoints, energy expenditure pathways, and lipid metabolism downstream effects. These compounds are typically the foundation of metabolic-axis research rather than being stacked with other classes.

Literature window

Metabolic-axis research typically reports endpoints across extended observation windows, with multi-week timeframes common in the published literature.

Compounds in this protocol

  • Retatrutide 10mg vial
    PRM-001 · Metabolic

    Retatrutide / 10mg

    Investigational triple agonist of GLP-1, GIP and glucagon receptors under research for metabolic regulation.

    ₱2,510₱2,790
    View vial
  • Tirzepatide 10mg vial
    PRM-006 · Metabolic

    Tirzepatide / 10mg

    Investigational dual agonist of GLP-1 and GIP receptors under research for incretin-mediated metabolic regulation.

03 · Research protocol

Mitochondrial Longevity

Mitochondrial-axis research compounds frequently co-studied in longevity literature.

Composition

2 compounds

1 in stock · 1 restock pending

Mitochondrial biologySirtuin pathwayAMPK signalingDNA repair pathways

NAD+ is studied as an essential coenzyme in cellular redox reactions, with research focusing on mitochondrial function, sirtuin activation, and DNA repair pathways. MOTS-c is a 16-residue mitochondrial-derived peptide investigated for AMPK signaling, glucose homeostasis, and mitochondrial biogenesis. The two appear together in longevity research that examines mitochondrial-axis interventions.

Literature window

Longevity research in this domain typically reports endpoints across extended observation windows where mitochondrial markers can be measured over time.

Compounds in this protocol

  • NAD+ 1000mg vial
    PRM-003 · Longevity

    NAD+ / 1000mg

    Essential coenzyme in cellular redox reactions; investigated in mitochondrial function and longevity research.

    ₱2,510₱2,790
    View vial
  • MOTS-c 20mg vial
    PRM-009 · Metabolic

    MOTS-c / 20mg

    Mitochondrial-derived 16-residue peptide investigated for AMPK activation, glucose homeostasis and mitochondrial biogenesis.

04 · Research protocol

GH Axis & Sleep Architecture

Growth hormone secretagogue research studying pulsatile GH release and downstream IGF-1 dynamics.

Composition

1 compound

0 in stock · 1 restock pending

GH secretagogueIGF-1 axisSleep architectureRecovery research

The CJC-1295 / Ipamorelin blend is a co-formulated growth hormone secretagogue studied for its effects on pulsatile GH release. Research explores downstream IGF-1 axis dynamics and secondary literature has examined effects on sleep architecture and recovery pathways. Investigators occasionally co-study this blend with soft-tissue repair compounds such as BPC-157 in broader recovery research contexts.

Literature window

Research in this area typically uses multi-week observation windows, with sleep-architecture endpoints reported across nightly measurement protocols.

Compounds in this protocol

  • CJC-1295 / Ipamorelin 5mg + 5mg vial
    PRM-007 · Recovery

    CJC-1295 / Ipamorelin / 5mg + 5mg

    Co-formulated growth hormone secretagogue blend studied for pulsatile GH release and downstream IGF-1 dynamics.

05 · Research protocol

Dermal Regeneration & Wound

Tissue-remodeling research compounds studied for collagen synthesis and wound healing.

Composition

2 compounds

2 in stock · 0 restock pending

Collagen synthesisWound healingAntioxidant responseDermal regeneration

GHK-Cu is a copper-binding tripeptide investigated for collagen synthesis, antioxidant gene expression, and dermal remodeling research. BPC-157 has been studied in parallel for wound healing and angiogenic mechanisms. The two are commonly investigated together in dermal regeneration literature, with research examining tissue-remodeling endpoints across skin, wound, and broader regenerative contexts.

Literature window

Dermal-regeneration research typically reports endpoints across multi-week observation windows where collagen and tissue-remodeling markers can be assessed.

Compounds in this protocol

  • GHK-Cu 50mg vial
    PRM-004 · Regenerative

    GHK-Cu / 50mg

    Copper-binding tripeptide investigated for dermal remodeling, wound healing and antioxidant gene expression.

    ₱1,030₱1,140
    View vial
  • BPC-157 20mg vial
    PRM-002 · Recovery

    BPC-157 / 20mg

    Pentadecapeptide derived from a protective gastric protein, studied for tissue repair and angiogenic activity.

    ₱2,020₱2,240
    View vial
Research use only

Every protocol references verified compounds.

Each vial in the protocols above is independently batch-verified before dispatch. First-time researchers get 10% off their first order automatically.